v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 23, 2026
Dec. 29, 2025
Jul. 25, 2025
Jul. 22, 2025
May 23, 2025
May 12, 2025
Sep. 03, 2024
May 15, 2024
Aug. 11, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Jul. 28, 2026
Dec. 31, 2025
Mar. 31, 2026
Jul. 28, 2025
Jul. 24, 2025
Jul. 11, 2025
Jul. 10, 2025
Jun. 22, 2025
Jun. 02, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Value of shares available for sale               $ 75,000,000                            
Aggregrate value       $ 79,075,969                                    
Common stock held       2,121,895                                    
Share price     $ 1.00                                     $ 37.65
Public float value                                         $ 75,000,000.0  
Stock issued during period, value, new issues                   $ 842,704 $ 2,858,046 $ 842,704 $ 2,963,738                  
Reverse stock split     15-for-1 reverse stock split                                      
Reverse stock split conversion     each 15 shares of issued and outstanding common stock and equivalents were consolidated into one share of common stock                                      
Common stock, shares outstanding     2,121,942             4,665,660   4,665,660     3,419,650     31,828,447        
Options outstanding     100,000                             1,900,000        
Common stock issuable upon exercise     800,000                           1,000,000.0 12,700,000        
Common stock, shares authorized                   350,000,000   350,000,000     350,000,000       350,000,000 112,500,000    
Dividend percentage                                 15.00%          
Dividend price per share                           $ 0.15                
Proceeds from sale of stock $ 4,797,848     $ 1,815,267     $ 5,500,000         $ 842,704 2,963,738                  
Prospectus supplement covers aggregate shares 12,202,152     8,184,733                                    
Remaining amount 5,202,152     3,684,733                                    
Additional prospectus supplement amount 7,000,000     $ 4,500,000                                    
Common stock par value                   $ 0.01   $ 0.01     $ 0.01              
Value of shares for compensation and fees                   $ 455,351   $ 455,351                    
May 2025 Warrant Exchange [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Common stock issuable upon exercise           333,334                                
Common stock par value           $ 0.01                                
Shares issued upon exercise of warrants           194,734                                
Common stock outstanding percentage           19.98%                                
Minimum [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Public float value                               $ 75,000,000            
At the Market Offering Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Value of shares available for sale $ 7,000,000                                          
Share price $ 0.01     $ 0.01                                    
Stock issued during period, value, new issues       $ 4,500,000       $ 5,500,000                            
Proceeds from sale of stock                       $ 842,702     $ 4,530,663              
Number of shares sold                       356,976     744,646              
At the Market Offering Agreement [Member] | Subsequent Event [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Proceeds from sale of stock                 $ 298,494                          
Number of shares sold                 162,804                          
Sales Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Proceeds from sale of stock $ 10,000,000     $ 5,500,000                                    
Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Number of shares issued         185,186                                  
Gross proceeds from offering         $ 3,300,000                                  
Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Share price   $ 3.61                                        
Number of shares issued   330,000                                        
Gross proceeds from offering   $ 7,000,000.0                                        
Common Stock [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Stock issued during period, value, new issues                   $ 3,570 $ 4,815 $ 3,570 $ 4,895                  
Sale of stock, consideration received on transaction                             $ 10,000,000              
Number of shares issued                   356,976 481,482 356,976 489,485                  
Number of shares for compensation and fees                   252,920   252,920                    
Value of shares for compensation and fees                   $ 2,529   $ 2,529                    
Common Stock [Member] | At the Market Offering Agreement [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Stock issued during period, value, new issues $ 7,000,000                                          
Pre-funded Warrants [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Warrants issued to purchase common stock         296,297                                  
Warrants exercise price         $ 0.0001                                  
Pre-funded Warrants [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Warrants issued to purchase common stock   1,609,114                                        
Warrants exercise price   $ 0.0001                                        
Warrant [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Warrants issued to purchase common stock         962,964                                  
Warrants exercise price         $ 6.75                                  
Warrant [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Warrants issued to purchase common stock   1,939,114                                        
Warrants exercise price   $ 3.482                                        
Warrants exercisable condition   The Company cannot effect the exercise of any December 2025 Pre-funded Warrant or December 2025 Warrant, and a holder will not be entitled to exercise any portion of any December 2025 Pre-funded Warrant or December 2025 Warrant, if, upon giving effect to such exercise, the aggregate number of shares of Common Stock beneficially owned by the holder (together with its affiliates) would exceed 9.99% or 4.99%, respectively, of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased or decreased at the holder’s election upon 61 days’ notice to the Company subject to the terms of such December 2025 Pre-funded Warrants or December 2025 Warrants, provided that such percentage may in no event exceed 19.99%                                        
Placement Agents Warrant [Member] | Securities Purchase Agreement [Member] | May 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Warrants issued to purchase common stock         24,075                                  
Warrants exercise price         $ 8.44                                  
Prefunded Warrant and Warrants [Member] | Securities Purchase Agreement [Member] | December 2025 Offering [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Share price   $ 3.6099                                        
Non-Affiliates [Member]                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Common stock held       2,100,291                                    
Officers and Director [Member[                                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                                            
Number of shares for compensation and fees                       49,135                    
Value of shares for compensation and fees                       $ 105,000